Five Faculty Assume New Leadership Roles at DCI
Andrew Berchuck, MD, and Jennifer Plichta, MD, MS, were named co-directors of Cancer Genetics at DCI. Gerald Grant, MD, was named co-leader of the DCI Neuro-Oncology Research Program. Chuan-Yuan Li, DSc, was named co-leader of the DCI Radiation Oncology and Imaging Research Program. Kris Wood, PhD, was appointed co-chair of the DCI Scientific Review Committee. READ
A PSA for Colorectal Cancer Awareness Month
Recently doctors have been seeing an increase in colorectal cancer in people younger than 50. In this new Duke Health video GI medical oncologist Niharika Mettu, MD, PhD, addresses this troubling trend and also talks about early detection and symptoms to watch out for. WATCH
Clinical Research News in Colorectal Cancer
Cancer Cells Camouflage Themselves to Survive Radio-therapy & Repopulate Tumors
New radiotherapy research co-led by Chuan-Yuan Li, DSc, co-program leader for DCI's Radiation Oncology and Imaging Research Program found that “giant” cancer cells camouflaged as healthy cells could survive a bout of radiotherapy, repair themselves, and become almost normal. This will have significant implications in avoiding relapse after radiotherapy. The findings were published in Advanced Science in January. READ
NEJM: New Guidance for Resection in Early-Stage Lung Cancer
Eighteen years and nearly 700 patients later, the results of the "Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer" clinical trial are in. Xiaofei Wang, PhD, a co-first author, and Thomas Stinchcombe, MD, a co-senior author, report in NEJM that the study establishes sublobar resection as standard of care. READ
DCI Sarcoma Team Encourages Early Assessment of Masses, Lesions
Approximately a year after formal creation of the Duke Sarcoma Center at DCI, the sarcoma team is reaching out to regional physicians to encourage assessment and early treatment for unusual presentations. Delayed diagnosis, treatment may increase risk of metastatic cancer. READ
(Warning: graphic image in article of a sarcoma)
WATCH: McManus Presents at GU ASCO on Disparities in Kidney Cancer Care
DCI medical oncology fellow Hannah Dzimitrowicz McManus, MD, presented her study of Medicare data that showed Black patients with metastatic renal cell carcinoma (kidney cancer) are less likely to receive immunotherapy. WATCH
Last month McManus published in JCO Oncology Practice on “End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy.”
Veterans with Early Stage Kidney Cancer the Focus of GU ASCO Conquer Cancer Award
Duke Radiation Oncology resident Shake Kumar, MD, received an ASCO Conquer Cancer Foundation GU Cancers Symposium Merit Award for his top-ranking abstract "Utilization of Local Treatment Modalities and Surveillance for Veterans with Early Stage Renal Carcinoma." READ
In an International Women's Day tribute Joanne Kurtzberg, MD, was named by BioPharma APAC as one of "12 Leading Women Who Transformed Cell & Gene Therapy" for her "significant contributions to the use of cord blood stem cells in the treatment of childhood diseases." Kurtzberg, a professor of Pediatrics and Pathology, is director of the Marcus Center for Cellular Cures at Duke. READ
"Despite It All, I Will Arise"
Duke Cancer Center Raleigh nurses and this mural —"Despite It All, I Will Arise"— by artist Georgia Tardy were featured this March in a Midtown Magazine article about art's power to heal. READ
At the inaugural MaryAnn Black Distinguished Health Equity Lecture hosted by DCI COEE last month, Chancellor Eugene Washington, MD, Kimberly E. Monroe, MPA, Nadine Barrett, PhD, and Black's sister Barbara, shared their memories of the Duke Health and Durham icon. Black was a career social worker who served in the NC House of Representatives. She was also associate vice president of community relations at DUHS. She passed away in 2020 from cancer. READ
Nussbaum Named to NCI Surgeon-Scientist Program Cohort
Daniel Nussbaum, MD, is one of 12 young surgeons nationwide to be selected by the National Institutes of Health/National Cancer Institute for the 2023 Early-Stage Surgeon Scientist Program. This pilot program brings together surgeon scientists from across the U.S.; building cohorts that will be trained together for up to three years per cohort. Nussbaum has also received a Duke Physician-Scientist Strong Start Award. For both projects, he will focus on pancreatic cancer metastasis to the liver. READ
MCR: Bass, Kastan, on ATM Regulation of the Cohesin Complex
Duke Department of Pharmacology & Cancer Biology investigators Thomas Bass, PhD, Donald Fleenor, PhD, Paige Burrell, and Michael Kastan, MD, PhD, published new work this month in Molecular Cancer Research on the ATM protein, which plays a central role in cell division and DNA repair: "ATM Regulation of the Cohesin Complex Is Required for Repression of DNA Replication and Transcription in the Vicinity of DNA Double-Strand Breaks." READ
Closing in on New Treatments
for Prostate Cancer
One in seven men are diagnosed with prostate cancer during their lifetimes.
For those who aren't cured by surgery or radiation, treatments that suppress the male hormone androgen can temporarily stop the disease from progressing. But at some point, hormone-based treatments stop working for most men.
A new finding published online in the Journal of Pathology — from a team led by Jiaoti Huang, MD, PhD, chair of Duke Pathology — points to a new avenue for developing a therapy that could help, without causing unwanted side effects. READ
CTC PSMA Status via Liquid Biopsy Could Complement PET Imaging, Guide Prostate Cancer Therapy
Prostate-specific membrane antigen (PSMA) expression on circulating tumor cells (CTCs) in men with metastatic castrate resistant prostate cancer increases upon disease progression during treatment with abiraterone or enzalutamide. PSMA-targeted radioligand therapy has dramatically improved clinical outcomes. "Recent prospective data from the PROPHECY trial sets the stage for a liquid biopsy of CTCs to assess PSMA expression that could complement PSMA PET imaging and identify men more or less likely to benefit from drugs that target PSMA," says Andrew Armstrong, MD, MSc, PROPHECY PI and senior author of a new paper published this month in Clinical Cancer Research. PROPHECY was funded in 2014 with a Prostate Cancer Foundation-Movember Challenge Award, and has resulted in eight publications so far, with more to come. LEARN MORE READ THE CCR PAPER
(strictly academic or clinical)
*Speakers include Afreen Shariff, MD, MBBS; Kerry Reynolds, MD (Mass. General); David Ortiz-Melo, MD; Michael Dougan, MD, PhD (Mass. General/Harvard Medical School); Sophia Weinmann, MD; Meenal Kheterpal, MD; Michel Khouri, MD; Suma Shah, MD; Coral Giovacchini, MD; Jon McDunn, PhD (Project Data Sphere); Yousuf Zafar, MD.
MARCH 22 @8 a.m. (via Zoom): DCI Seminar Series “Translating the Genome in Gastroesophageal Cancer (and some views from the other side...)”
Features Adam Bass, MD, Global Head, ONC Translational Research, Oncology NIBR, Novartis Institutes for Biomed, Research, Inc.
Presented by DCI Precision Cancer Medicine and Investigational Therapeutics (PCMIT)
Email Joan Lofton, MBA, to register/get Zoom link
MARCH 25-28: Society for Gynecologic Oncology (SGO) Annual Meeting (Tampa, FL.) Angeles Alvarez Secord, MD, MHSc, to be inducted as SGO’s new president.
MARCH 30 (in-person): Faculty Lectures by Cagla Eroglu, PhD, and Andrew West, PhD (SoM Dean's Research Series)
(1p to 2:30p): Trainee Poster Session
LOCATION: Great Hall, Trent Semans Center for Health Education, & live-streamed
MARCH 31 TO APRIL 2 (in-person): NCCN Annual Conference REGISTER (Orlando World Center Marriott)
*Speakers include Therese Hennig, MPAS, PA-C; Scott Winkel, MHS, MSPH, PA-C; Donna Adams, NP; Emily Sellars, RN, MSN, ANP-C; Krista Rowe Nichols, RN, MSN, AOCNS; Tanya Helms, PA-C, R.Ph; Ahmed Galal, MD; Katharine Ciarrocca, DMD, MSEd; Kevin Oeffinger, MD; Harry Erba, MD, PhD; Emily Curran, MD (Univ. of Cinn.); Patrick Stiff, MD (Loyola); Lindsay Rein, MD; Mitch Horwitz, MD; Richard Stone, MD (Harvard); Harry Erba, MD, PhD; Cristiana Chase, DO; Clifton Mo, MD (Harvard); Taewoong Choi, MD; Cristiana Chase, DO; Yubin Kang, MD; Bill Wierda, MD (MD Anderson); Andrea Sitlinger, MD; Danielle Brander, MD; Andrea Sitlinger, MD; Bill Wierda, MD; Mazyar Shadman, MD, MPH (Fred Hutch); Basem William, MD, MRCP, FACP; Matthew McKinney, MD
(general public welcome)
Duke RadOnc found some old photos while reorganizing their business suite. Guess the year.
Julie Poucher Harbin, Senior Writer, DCI, is Managing Editor of the DCI E-News & the DCI Blog.
FILL OUT THIS FORM to submit announcements of upcoming events; new faculty, fellows, or residents; honors, awards, recognitions, new roles, promotions; and other news you wish to share
for potential inclusion in the next DCI E-news or internal channels.
Copyright © 2023 Duke Cancer Institute, All rights reserved.
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
20 Duke Medicine Circle | Durham, NC 27710 US
This email was sent to email@example.com.
To continue receiving our emails, add us to your address book.